{"id":839172,"date":"2025-04-18T19:03:11","date_gmt":"2025-04-18T23:03:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/"},"modified":"2025-04-18T19:03:11","modified_gmt":"2025-04-18T23:03:11","slug":"new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/","title":{"rendered":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Latest approval expands Medtronic CGM portfolio in the U.S.<\/i>\n <\/p>\n

\n GALWAY, Ireland<\/span><\/span>, April 18, 2025<\/span><\/span> \/PRNewswire\/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync\u2122 sensor for use with the MiniMed\u2122 780G system. With this approval, the MiniMed\u2122 780G system now offers more flexibility for users of the company’s most advanced insulin delivery system featuring Meal Detection\u2122 technology with both the Guardian\u2122 4 sensor and Simplera Sync\u2122 sensor.<\/p>\n

The Simplera Sync\u2122 is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard\u2122 or overtape and features a simple, two-step insertion process. It is the company’s newest addition to its CGM portfolio, which expands options and provides greater flexibility for users.**<\/p>\n

The MiniMed\u2122 780G system’s adaptive algorithm automatically anticipates, adjusts, and corrects\u2020<\/sup> glucose levels every 5 minutes, 24\/7 \u2013 working around the clock so users can focus on what matters.\u00a7<\/sup> It’s the only system featuring Meal Detection\u2122 technology\u2021<\/sup><\/i>, which detects rising sugar levels and delivers more insulin as needed to help users keep glucose levels in range more often \u2013 even when users occasionally forget to dose insulin for snacks or meals or underestimate their carbs. The system uses a “treat to target” approach and flexible glucose targets as low as 100 mg\/dL, which, combined with its adaptive algorithm allows it to more closely mirror the glucose levels of someone not living with diabetes. Real-world data of the system shows global users consistently achieve time in range above international targets of 70% when using optimal settings (active insulin time of two hours and 100 mg\/dL target glucose).1-3<\/sup> It is also the only system that works with the world’s only infusion set that lasts up to 7 days so that users only have to change their infusion set once per week and can experience 96% fewer injections compared to multiple daily injections.<\/p>\n

“We’re committed to driving innovation that makes life easier for those living with diabetes so they can forget about their diabetes as much as possible throughout the day,” said Que Dallara, EVP and president of Medtronic Diabetes. “Our MiniMed\u2122 780G system delivers advanced diabetes technology for so many around the world, and we’re excited to continue evolving this experience with expanded CGM options \u2014including our Simplera Sync\u2122 sensor, which we look forward to bringing to people living with diabetes in the U.S.”<\/p>\n

A limited launch of the Simplera Sync\u2122 sensor will begin in the U.S. in the fall of 2025. Today, the MiniMed\u2122 780G system can be used with the Guardian\u2122 4 sensor.<\/p>\n

\n
\n About the Diabetes Business at<\/u>
\n <\/b>\u00a0Medtronic<\/u><\/b>\u00a0(www.medtronicdiabetes.com<\/a>)
\u00a0Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced diabetes technology and always-on support when and how they need it. We’ve pioneered first-of-its-kind innovations for over 40 years and are committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront.<\/p>\n

\n
\n About Medtronic<\/u>
\n <\/b>
\n
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland<\/span>, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission \u2014 to alleviate pain, restore health, and extend life \u2014 unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com<\/a> and follow Medtronic on LinkedIn<\/a>.<\/p>\n

\n *Fingersticks required in manual mode & to enter SmartGuard. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
<\/i>
\n **Participants in a clinical trial reported the sensor was smaller and lighter than other sensors they have used. Data on file: CIP330, N=243, ages 2-80.
<\/i>
\n \u2020Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
<\/i>
\n \u00a0\u2021Taking a bolus 15 \u2013 20 minutes before a meal helps to keep blood sugar levels under control after eating. <\/i>
\n
\n \u00a0\u00a7 Refers to SmartGuard\u2122 feature. Individual results may vary.<\/i>\n <\/p>\n

    \n
  1. \n Choudhary P. et al, Lancet Diabetes\u00a0Endocrinol. <\/i>
    \n 2022;\u00a0https:\/\/doi.org\/10.1016\/ S2213-8587(22)00245-5<\/i>\n <\/li>\n
  2. \n Arrieta A, et al. Diabetes Obes Metab. <\/i>
    \n 2022;10.1111\/dom.14714<\/i>\n <\/li>\n
  3. \n Matejko B, et al. <\/i>
    \n Diabetes Care 2022;45:2628\u20132635<\/i>\n <\/li>\n<\/ol>\n

    \u00a0<\/p>\n

    \n\n\n\n\n\n
    \n

    \n
    \n Contacts:<\/u>\u00a0<\/span>\n <\/p>\n<\/td>\n

    		\n \n <\/td>\n<\/tr>\n
    \n

    \n Ashley Patterson<\/span>\n <\/p>\n<\/td>\n

    		\n

    \n Ryan\u00a0Weispfenning\u00a0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

    \n

    \n Public Relations<\/span>\n <\/p>\n<\/td>\n

    		\n

    \n Investor Relations\u00a0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

    \n

    \n +1-818-576-3025<\/span>\n <\/p>\n<\/td>\n

    		\n

    \n +1-763-505-4626\u00a0<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

    \u00a0<\/p>\n

    \n

    \n
    \n \"MiniMed\u2122
    \n <\/a>\n <\/p>\n<\/p><\/div>\n

    \u00a0<\/p>\n

    \n

    \n
    \n \"(PRNewsfoto\/Medtronic
    \n <\/a>\n <\/p>\n<\/p><\/div>\n

    \n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved-302432787.html<\/a><\/p>\n

    SOURCE Medtronic plc<\/p>\n<\/p><\/div>\n

    \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

    PR Newswire Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 \/PRNewswire\/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync\u2122 sensor for use with the MiniMed\u2122 780G system. With this approval, the MiniMed\u2122 780G system now offers more flexibility for users of the company’s most advanced insulin delivery system featuring Meal Detection\u2122 technology with both the Guardian\u2122 4 sensor and Simplera Sync\u2122 sensor. The Simplera Sync\u2122 is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard\u2122 or overtape and features a simple, two-step insertion process. It is the company’s newest addition to its CGM portfolio, which expands … <\/p>\n

    Continue reading “New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839172","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNew Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 \/PRNewswire\/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync\u2122 sensor for use with the MiniMed\u2122 780G system. With this approval, the MiniMed\u2122 780G system now offers more flexibility for users of the company’s most advanced insulin delivery system featuring Meal Detection\u2122 technology with both the Guardian\u2122 4 sensor and Simplera Sync\u2122 sensor. The Simplera Sync\u2122 is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard\u2122 or overtape and features a simple, two-step insertion process. It is the company’s newest addition to its CGM portfolio, which expands … Continue reading "New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-18T23:03:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved\",\"datePublished\":\"2025-04-18T23:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/\"},\"wordCount\":845,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2668551\\\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/\",\"name\":\"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2668551\\\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg\",\"datePublished\":\"2025-04-18T23:03:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2668551\\\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2668551\\\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/","og_locale":"en_US","og_type":"article","og_title":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk","og_description":"PR Newswire Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 \/PRNewswire\/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync\u2122 sensor for use with the MiniMed\u2122 780G system. With this approval, the MiniMed\u2122 780G system now offers more flexibility for users of the company’s most advanced insulin delivery system featuring Meal Detection\u2122 technology with both the Guardian\u2122 4 sensor and Simplera Sync\u2122 sensor. The Simplera Sync\u2122 is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard\u2122 or overtape and features a simple, two-step insertion process. It is the company’s newest addition to its CGM portfolio, which expands … Continue reading \"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-18T23:03:11+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved","datePublished":"2025-04-18T23:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/"},"wordCount":845,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/","name":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg","datePublished":"2025-04-18T23:03:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2668551\/Medtronic_plc___MiniMed_780G_system_with_Simplera_Sync_sensor.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-simplera-sync-sensor-for-the-minimed-780g-system-now-fda-approved\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"New Simplera Sync\u2122 sensor for the MiniMed\u2122 780G System now FDA approved"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839172"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839172\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}